Classes
- Tumor markers and their importance in gynecologyED0005174 | Faculty of Medicine in Pilsen
- Medical Genetics in Obstetrics and GynaecologyED0005102 | Faculty of Medicine in Pilsen
- Clinical Immunology in Obstetrics and GynaecologyED0005103 | Faculty of Medicine in Pilsen
- The woman in high - risk pregnancy and her newborn +1ED0005104 | Faculty of Medicine in Pilsen
- Conference - Presentation of research results: Thrombophilic factors and recurrent pregnancy loss - the multifactorial modelED0005110 | Faculty of Medicine in Pilsen
- The woman at immnunological risk and her infantED0005143 | Faculty of Medicine in Pilsen
- Malignant vulvar lesionsED0005170 | Faculty of Medicine in Pilsen
- ? +15ED0005171 | Faculty of Medicine in Pilsen
- Microbiology of Lower Genital TractED0005173 | Faculty of Medicine in Pilsen
- Screening and prevention of gynecological tumorsED0005175 | Faculty of Medicine in Pilsen
Publications
- Effect of overweight on the outcome of assisted reproductive technology in infertile women2014 | Faculty of Medicine in Pilsen
- HE4 and other markers in ovarian cancer2013 | Publication without faculty affiliation
- Changes of serum levels of tumor markers in ovarian cancer and benign diseases2012 | Faculty of Medicine in Pilsen
- Comparison of selective oxidative stress parameters in the follicular fluid (FF) of infertile women and healthy fertile oocyte donors2012 | Faculty of Medicine in Pilsen
- Test of ovarian cancer multiplex xMAP technology panel2009 | Central Library of Charles University
- Are the antibodies against laminin-1 the signifikant marker of decreased fertility in women?2007 | Central Library of Charles University
- Markers of oxidative stress in diabetic mothers and their infants during delivery2005 | Faculty of Medicine in Pilsen
- Changes of oxidative stress markers during pregnancy and labour2002 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine, Second Faculty of Medicine
- Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...